Issue 6/2001
Content (12 Articles)
8-Cl-adenosine is an active metabolite of 8-Cl-cAMP responsible for its in vitro antiproliferative effects on CHO mutants hypersensitive to cytostatic drugs
Susan K. Robbins, Susan Houlbrook, John D. Priddle, Adrian L. Harris
The experimental neuroprotectant leukaemia inhibitory factor (LIF) does not compromise antitumour activity of paclitaxel, cisplatin and carboplatin
Frances M. Boyle, Cecilie Beatson, Robyn Monk, Susan L. Grant, John B. Kurek
Phase I/II and pharmacologic study of irinotecan and carboplatin for patients with lung cancer
Mitsuo Sato, Masahiko Ando, Hironobu Minami, Yuichi Ando, Maki Ando, Masashi Yamamoto, Shuzo Sakai, Atsushi Watanabe, Takuya Ikeda, Yoshitaka Sekido, Hideo Saka, Kaoru Shimokata, Yoshinori Hasegawa
Phase I clinical and pharmacokinetic trial of irofulven
James P. Thomas, Rhoda Arzoomanian, Dona Alberti, Chris Feierabend, Kimberly Binger, Kendra D. Tutsch, Thomas Steele, Rebecca Marnocha, Charlotte Smith, Sheri Smith, John MacDonald, George Wilding, Howard Bailey
Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokinetics
David Z. Chang, Thomas Olencki, Thomas G. Budd, David Peereboom, R. Ganapathi, Bruno Osterwalder, Ronald Bukowski
A comparison of limited sampling strategies for prediction of Ecteinascidin 743 clearance when administered as a 24-h infusion
Charlotte van Kesteren, R. Mathôt, L. López-Lázaro, E. Cvitkovic, A. Taamma, J. Jimeno, C. Guzman, J. Schellens, J. Misset, E. Brain, M. Hillebrand, H. Rosing, J. Beijnen
Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer
Mikio Oka, Minoru Fukuda, Seiji Nagashima, Masaaki Fukuda, Akitoshi Kinoshita, Hiroshi Soda, Seiji Doi, Fumihiko Narasaki, Mitsuhiro Suenaga, Hiroshi Takatani, Yo-ichi Nakamura, Shigeru Kawabata, Junji Tsurutani, Tetsuro Kanda, Shigeru Kohno
Gemcitabine activity in cervical cancer cell lines
Patricia Hernández, Primitivo Olivera, Alfonso Dueñas-Gonzalez, Miguel A. Pérez-Pastenes, Adolfo Zárate, Vilma Maldonado, Jorge Meléndez-Zajgla
Antiangiogenic and antitumor effects of a protein kinase Cβ inhibitor in murine Lewis lung carcinoma and human Calu-6 non-small-cell lung carcinoma xenografts
Beverly A. Teicher, Krishna Menon, Enrique Alvarez, Elizabeth Galbreath, Chuan Shih, Margaret M. Faul
A phase II study of paclitaxel plus cisplatin for advanced non-small-cell lung cancer in Japanese patients
Hiroshi Sakai, Shuichi Yoneda, Tomohide Tamura, Yutaka Nishiwaki, Akira Yokoyama, Koshiro Watanabe, Nagahiro Saijo
Stereospecific antitumor activity of radicicol oxime derivatives
Shiro Soga, Sreenath V. Sharma, Yukimasa Shiotsu, Makiko Shimizu, Harunobu Tahara, Kazuo Yamaguchi, Yoji Ikuina, Chikara Murakata, Tatsuya Tamaoki, Junichi Kurebayashi, Theodor W. Schulte, Leonard M. Neckers, Shiro Akinaga
Doxorubicin-induced apoptosis in caspase-8-deficient neuroblastoma cells is mediated through direct action on mitochondria
Abdelhadi Rebbaa, Pauline M. Chou, Mohammad Emran, Bernard L. Mirkin